Related Experiment Video
Updated: Aug 13, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3
Neil S Sheerin1, Katsushige Abe, Paul Risley
1Department of Nephrology and Transplantation, Guy's Hospital, King's College London, UK. neil.sheerin@kcl.ac.uk
Insights
Circulating complement component 3 (C3) is crucial for preventing immune complex buildup in the kidneys, significantly reducing disease severity in glomerulonephritis. Local C3 production within the kidney plays a minor role in this protective effect.
Area of Science:
- Immunology
- Nephrology
- Complement System
Background:
- Complement activation can exacerbate immune complex glomerulonephritis.
- The third complement component (C3) can also resolve immune complexes, potentially mitigating disease.
- The role of kidney-produced C3 in this balance remains unclear.
Purpose of the Study:
- To investigate the distinct roles of systemic versus local C3 production in a mouse model of glomerular immune complex disease.
- To determine whether circulating or kidney-derived C3 is more critical for managing immune complex glomerulonephritis.
Main Methods:
- Utilized a mouse model of glomerulonephritis induced by anti-glomerular basement membrane antibody.
- Employed C3-deficient mice and kidney transplantation between C3-sufficient and C3-deficient mice.
- Assessed immune complex accumulation, glomerular structure, and kidney function over 14 days.
Main Results:
- C3-deficient mice exhibited significantly more severe glomerular immune complex disease and kidney dysfunction compared to C3-sufficient mice.
- Kidney injury severity correlated with the recipient's circulating C3 levels, irrespective of the transplanted kidney's C3 production capacity.
- High circulating C3 levels preserved glomerular structure and function, while C3 deficiency led to severe disease.
Conclusions:
- Circulating C3 is a critical factor in limiting glomerular immune complex deposition and reducing glomerulonephritis severity.
- Local C3 synthesis within the kidney does not significantly influence the glomerular accumulation of immune complexes in this model.
Abstract:
Although complement activation can make immune complex glomerulonephritis worse, the third complement component also can solubilize immune complexes and thus reduce the severity of disease. How C3 that is produced within the kidney contributes to this balance is unknown. This study therefore investigated the relative roles of systemic and local C3 production in a model of glomerular immune complex disease. Injection of sheep anti-glomerular basement membrane antibody into preimmunized mice resulted in accumulation of immune complexes and progressive loss of function over 14 d that was much more marked in C3-deficient (C3-/-) mice. In C3-sufficient mice that received a transplant of a C3-/- mouse kidney and in C3-/- mice with C3-sufficient mouse kidney transplants, the severity and the pattern of injury went with the complement status of the recipient. That is, mice with deficient circulating C3 developed severe glomerular immune complex disease, whereas those with a high level of circulating C3 had well-preserved glomerular structure and function. It is concluded that circulating C3 is a critical factor in reducing the glomerular accumulation of immune complexes. Local synthesis of C3 did not have a major influence on this aspect of glomerular disease.
Related Concept Videos
Hypersensitivity Reactions: Immune-Complex Reactions
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Complement System
Chronic Inflammation: Introduction
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
